Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How does residual DCIS after neoadjuvant chemotherapy impact prognosis if there is a CR of the invasive disease?
Answer from: Radiation Oncologist at Community Practice
The majority of studies suggest residual DCIS has the same outcome as pCR with no invasive disease and thus is still treated as pCR in practice.
Sign in or Register to read more
17488
Related Questions
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?